… of various types of cancers. However, its role in non-small cell lung cancer (NSCLC) has not
… malignant phenotype of human NSCLCs. In functional experiments, miR-146a suppressed …

… of DC-activated CIK cells in improvement of chemotherapy for malignant tumor treatment is
associated with up-regulation of the production of cytokines involved in the anti-tumor effect. …

… tumour cells can affect immune system responses, we investigated the effects of tumour cell
lines on CD4 + T cells … , but not all, SCLC tumour cell lines constitutively secrete molecules …

… impact of these molecular markers in tumor cells and tumor stroma of resected non-small cell
lung cancer (NSCLC) tumors… tumor cells in tumor cores and intensity and density of stromal …

… cell lung cancer (NSCLC) cell lines in combination with lung fibroblasts. This model allows
the investigation of tumour-… the importance of having a more in vivo like cell culture model. …

… + cytotoxic T cells among regulatory T cells seems to mitigate this effect and was … tumor
and immune cell types and exploration of its use as a prognostic factor in lung cancer treatment …

… -onset symptoms due to local intrathoracic tumour growth, … first-line treatment for metastatic
small-cell lung cancer. For non-… Lung cancer accounts for 12% of all new cases of cancers …

… Figure 4 Survival analysis in 81 low vascular grade cases with low TP cancer cells reactivity.
Stratification for fibroblast TP reactivity (FR) and degree of macrophage infiltration (Ml) ----, A…

… ) prognostic impact. Conclusion: The present study shows that disseminated cancer cells in
… of the patients with operable non-small cell lung cancer and that they are associated with a …

… of these molecular markers in tumor cells as well as in the tumor stroma of resected non–small
cell lung cancer tumors. Experimental Design: Tumor tissue samples from 335 resected …